Cutting-edge drug resistance analysis of major cancers at single-cell level

Tianyu Liu1, Zhiyuan Cao1, Wenxin Long2

  • 1Yale University, New Haven, 06520, CT, USA.

Insights

Cancer cells can become resistant to treatments, posing a significant challenge. This review explores how single-cell analysis reveals mechanisms of drug resistance and tolerance, crucial for overcoming treatment failures.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Drug resistance in cancer cells is a major obstacle to effective treatment.
  • Understanding the mechanisms of drug tolerance and resistance is critical for improving patient outcomes.
  • Tumor heterogeneity complicates the analysis of drug resistance at the cellular level.

Purpose of the Study:

  • To review recent advances in analyzing cell-level drug resistance.
  • To explore the sources, kinetics, and interactions of drug resistance mechanisms.
  • To highlight the role of single-cell multi-omic sequencing in understanding drug tolerance and resistance.

Main Methods:

  • Review of current literature on single-cell analysis techniques.
  • Discussion of single-cell multi-omic sequencing for drug resistance studies.
  • Analysis of inter- and intra-tumor heterogeneity in drug resistance.

Main Results:

  • Single-cell analysis offers promising avenues to investigate drug resistance sources and development.
  • Cell states and cancer heterogeneity are linked to drug resistance.
  • Single-cell multi-omic sequencing is a powerful tool for studying drug tolerance and resistance.

Conclusions:

  • Advances in single-cell analysis are crucial for understanding and overcoming cancer drug resistance.
  • Methodological improvements are needed to fully leverage single-cell multi-omic data.
  • Targeting cell-level drug resistance mechanisms can improve cancer treatment strategies.